( OTC-BB:SNDC, OTC-BB:VOLN )

News from VolitionRX Limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 02, 2017, 08:30 ET VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update

Conference call to take place Friday, November 10, 2017 at 8:30 am Eastern time VolitionRx Limited (NYSE American: VNRX) today announced it...


Sep 21, 2017, 16:30 ET VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded a loan and a non-repayable grant totaling $1.5...


Aug 03, 2017, 16:30 ET VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

Conference call to take place Thursday, August 10, 2017 at 8:30 am Eastern time VolitionRx Limited (NYSE AMERICAN: VNRX) today announced it...


Jul 19, 2017, 16:30 ET VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

VolitionRx Limited (Volition; NYSE MKT: VNRX), announced it will host a conference call tomorrow, July 20 at 8:30 AM U.S. Eastern Time to discuss...


May 26, 2017, 06:30 ET VolitionRx Limited to Present at Multiple Investor Conferences in June

VolitionRx Limited (NYSE MKT: VNRX) today announced it is scheduled to present at multiple investor conferences in June. Dr. Scott Powell,...


May 11, 2017, 06:30 ET VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update

VolitionRx Limited (NYSE MKT: VNRX) ("Volition") today announced financial results for the quarter ended March 31, 2017 and provided a business...


Apr 21, 2017, 08:26 ET Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory

VolitionRx Limited (NYSE MKT: VNRX) opened its new research and development facility this week. A video showcasing the new facility and...


Mar 28, 2017, 16:01 ET Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Volition America, Inc., a wholly-owned U.S. subsidiary of VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of Deborah Vollmer...


Mar 20, 2017, 06:30 ET VolitionRx Limited Announces the Formation of Volition America, Inc.

VolitionRx Limited (NYSE MKT: VNRX) today announced the creation of a wholly-owned U.S. subsidiary, Volition America, Inc., which will be based in...


Mar 14, 2017, 13:56 ET VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

VolitionRx Limited (NYSE MKT: VNRX) celebrated the company's recent announcement of a CE mark for its Nu.QTM Colorectal Cancer Screening Triage...


Mar 13, 2017, 06:30 ET VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

VolitionRx Limited (NYSE MKT: VNRX) announced today that members of its senior management team and Board of Directors, including Chief Executive...


Feb 06, 2015, 08:00 ET VolitionRx Limited Prices Public Offering of Common Stock

VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types...


Nov 24, 2014, 08:00 ET VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced...


Nov 05, 2014, 08:00 ET VolitionRx to Present at the SeeThruEquity Conference

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and...


Oct 31, 2014, 08:00 ET VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced...


Oct 02, 2014, 08:00 ET VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Sep 05, 2014, 06:30 ET VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference

 VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer...


Dec 02, 2013, 06:30 ET VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 29, 2013, 08:30 ET VolitionRx to Present at the 6th Annual LD Micro Conference

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 14, 2013, 06:30 ET VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 07, 2013, 06:30 ET First VolitionRx Study Data Presented at CNAPS, Baltimore

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


Sep 26, 2013, 06:30 ET VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


Sep 03, 2013, 06:30 ET VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is...


Jul 22, 2013, 06:30 ET VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive...


May 01, 2013, 06:30 ET Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic

VolitionRx Limited (OTC: VNRX), a life sciences company that is developing blood-based diagnostic tests for different types of cancer, has retained...